Clinical Trials in Baltimore

Showing 5881-5900 of 23,476 trials

Using Technology to Track Pain and Pain-related Outcomes

NCT04267588

Persistent pain is a public health epidemic. The current protocol seeks to develop technology to aid patients' tracking of patients' pain, medications and pain-related variables. The investigators seek to talk with patients in co-investigator's clinic to solicit feedback, as well as pilot test the technology with pain patients.

Pain, Chronic

Johns Hopkins University100 participantsStarted Aug 2020

Baltimore, Maryland, United States

RECRUITINGNA< 1 mile

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

NCT05924477

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.

Glaucoma

University of Pennsylvania226 participantsStarted Jul 2023

San Francisco, California, United States • Walnut Creek, California, United States • Miami, Florida, United States +5 more locations

COMPLETED< 1 mile

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

NCT03279185

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.

HIV/AIDS

Harvard School of Public Health (HSPH)334 participantsStarted Nov 2017

Los Angeles, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +6 more locations

Using Technology to Track Pain and Pain-related Outcomes

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Find Trials by Condition in Baltimore

Adolescent Master Protocol

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

LTFU for All Cell and Gene Therapy Studies

A Nutritional Intervention in Police Officers

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

Gluten Technology and Education for Celiac Health

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

Cough Reduction in IPF With Nalbuphine ER

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics